Skip to content
10-Q

Quarterly Report

NEPHROS, INC. NEPH

0001493152-24-045793

← back to feed
Filed
Nov 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 4, 2024 10.54M sh
Cash And Equivalents Q3 2024 · Sep 30, 2024 $2.46M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $4.31M
Current Liabilities Q3 2024 · Sep 30, 2024 $1.06M
Current Liabilities Q3 2024 · Dec 31, 2023 $2.11M
Total Liabilities Q3 2024 · Sep 30, 2024 $2.21M
Total Liabilities Q3 2024 · Dec 31, 2023 $3.5M
Current Assets Q3 2024 · Sep 30, 2024 $7.36M
Current Assets Q3 2024 · Dec 31, 2023 $8.41M
Total Assets Q3 2024 · Sep 30, 2024 $10.39M
Total Assets Q3 2024 · Dec 31, 2023 $11.86M
Shares Diluted Q3 2024 · Sep 30, 2023 10.46M sh
Shares Diluted Q3 2024 · Sep 30, 2023 10.35M sh
Operating Cash Flow Q3 2024 · Sep 30, 2023 $1.06M
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.02
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.09
Eps Basic Q3 2024 · Sep 30, 2023 −$0.02
Eps Basic Q3 2024 · Sep 30, 2023 −$0.09
Sga Expense Q3 2024 · Sep 30, 2023 $2.14M
Sga Expense Q3 2024 · Sep 30, 2023 $6.5M
Rd Expense Q3 2024 · Sep 30, 2023 $205K
Rd Expense Q3 2024 · Sep 30, 2023 $665K
Net Income Q3 2024 · Sep 30, 2023 −$182K
Net Income Q3 2024 · Sep 30, 2023 −$921K
Net Income Q3 2024 · Jun 30, 2023 −$433K
Net Income Q3 2024 · Mar 31, 2023 −$306K
Operating Income Q3 2024 · Sep 30, 2023 −$203K
Operating Income Q3 2024 · Sep 30, 2023 −$944K
Gross Profit Q3 2024 · Sep 30, 2023 $2.19M
Gross Profit Q3 2024 · Sep 30, 2023 $6.38M
Cost Of Revenue Q3 2024 · Sep 30, 2023 $1.55M
Cost Of Revenue Q3 2024 · Sep 30, 2023 $4.6M
Revenue Q3 2024 · Sep 30, 2023 $3.74M
Revenue Q3 2024 · Sep 30, 2023 $10.98M